A study on intraocular diffusion following intravenous administration of gadolinium-based contrast agents in patients with glaucoma

A study on intraocular diffusion following intravenous administration of gadolinium-based contrast agents in patients with glaucoma - A study on intraocular diffusion following intravenous administration of gadolinium-based contrast agents in patients with glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061317

Enrollment

Registered

2026-06-01

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Glaucoma patient

Exclusion criteria

Exclusion criteria: Patients with hypersensitivity or allergy to gadolinium-based contrast agents Patients with severe renal impairment or those on dialysis Pregnant patients Breastfeeding patients Patients with asthma Patients who are unable to undergo MRI examination Patients with claustrophobia

Design outcomes

Primary

Measure	Time frame
Contrast Shift Index of a gadolinium-based contrast agent	—

Secondary

Measure	Time frame
Factors determining the contrast shift index	—

Countries

Japan

Contacts

Public ContactKenya Yuki

Nagoya University Graduate School of Medicine Department of Ophthalmology

yuki.kenya.z9@f.mail.nagoya-u.ac.jp052-741-2111

Outcome results